EU GMP Chapter 9, as it stands today, is one principle and three clauses. Listed areas should be examined to a pre-arranged program, by designated competent persons from the company working independently; every self inspection should be recorded, and so should the actions taken afterwards. The list of areas includes self inspection itself.
A URS line such as 'the HVAC system shall maintain suitable conditions' cannot be tested. EU GMP Annex 15 (2015) says the URS should be a point of reference throughout the validation life cycle. Five checks make a line usable: one requirement, a unique ID, a number with unit and tolerance, the state, and a named test.
In a comparative method transfer, two laboratories test the same lots. EU GMP Chapter 6 says the transfer should be described in a detailed protocol, with acceptance criteria based upon the current validation study of the method. Agree the criteria before execution, train the analysts, compare the results against the criteria and investigate deviations before closure.
A pharmacopoeial method was validated before it was published, but not in your laboratory or on your product. EU GMP Chapter 6 says a laboratory that did not perform the original validation should verify the method's appropriateness, and WHO's validation guideline describes verification as partial validation, with specificity for the product shown.
A nightly backup means up to 24 hours of data can be lost. That is a recovery point objective, RPO, whether or not anyone chose it. The recovery time objective, RTO, is how long the system may stay down. Both should be written down, signed by QA and proven with a timed restore test.
ICH Q1A(R2) says stability storage equipment should be capable of holding the condition within tolerance, for example 25 °C ± 2 °C and 60% RH ± 5% RH. Showing that takes mapping at each setpoint, independent monitoring, recovery tests, a written backup plan and sensors calibrated at the setpoints in use.
EU GMP Annex 15 (2015) describes three approaches to process validation: the traditional one, with a justified number of batches under routine conditions; continuous process verification for products developed by quality by design; and a hybrid of the two. Ongoing process verification should follow whichever is used.
A loose page with no number and no version cannot be traced. The 2011 text of EU GMP Chapter 4 says documents should be uniquely identifiable, and that instructions should be approved, signed and dated, with the effective date defined. Most sites meet it with number, version, effective date and page x of y on every page.
"Quality is QA's job" is not how the GMP texts read. The 2013 text of EU GMP Chapter 1 makes the quality objective the responsibility of senior management, with staff in many departments taking part. Chapter 2 lists qualification and maintenance of premises and equipment among the duties the heads of Production and Quality Control generally have.
ICH Q2(R2) says validation demonstrates that an analytical procedure is fit for its intended purpose. A study typically shows specificity or selectivity, a range with suitable response and lower limits, accuracy and precision; robustness is typically evaluated in development under ICH Q14. Validated for one sample type does not mean validated for another.
Cleaning validation is often reduced to showing the previous product is gone. EU GMP Annex 15 (2015) also says limits should be established for cleaning agents, microbial and endotoxin risk should be considered when protocols are developed, and the times before and after cleaning should be used to define dirty and clean hold times.
Every SKU changeover on a packaging line is a chance for a leaflet or label from the previous run to reach the next. EU GMP Chapter 5 says line clearance should follow an appropriate checklist. Five checks cover it: nothing left behind, printed materials matched, counters at zero, bins empty, a second-person check.